AU8083401A - Biologically active macrolides, compositions, and uses thereof - Google Patents

Biologically active macrolides, compositions, and uses thereof

Info

Publication number
AU8083401A
AU8083401A AU8083401A AU8083401A AU8083401A AU 8083401 A AU8083401 A AU 8083401A AU 8083401 A AU8083401 A AU 8083401A AU 8083401 A AU8083401 A AU 8083401A AU 8083401 A AU8083401 A AU 8083401A
Authority
AU
Australia
Prior art keywords
aryl
alkyl
alkenyl
present
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8083401A
Other languages
English (en)
Inventor
Michael R Boyd
Kirk R Gustafson
Charles L Cantrell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU8083401A publication Critical patent/AU8083401A/xx
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AU8083401A 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof Pending AU8083401A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22027000P 2000-07-24 2000-07-24
PCT/US2001/023633 WO2002008231A2 (en) 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof

Publications (1)

Publication Number Publication Date
AU8083401A true AU8083401A (en) 2002-02-05

Family

ID=22822844

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8083401A Pending AU8083401A (en) 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof
AU2001280834A Ceased AU2001280834B2 (en) 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001280834A Ceased AU2001280834B2 (en) 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof

Country Status (8)

Country Link
US (5) US7144918B2 (enExample)
EP (1) EP1303522B1 (enExample)
JP (1) JP4980542B2 (enExample)
AT (1) ATE504589T1 (enExample)
AU (2) AU8083401A (enExample)
CA (1) CA2415611C (enExample)
DE (1) DE60144376D1 (enExample)
WO (1) WO2002008231A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8083401A (en) * 2000-07-24 2002-02-05 Us Health Biologically active macrolides, compositions, and uses thereof
WO2004009079A1 (en) 2002-07-24 2004-01-29 The Government Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services Chondropsin-class antitumor v-atpase inhibitor compounds, compositions and methods of use thereof
WO2010144611A2 (en) * 2009-06-10 2010-12-16 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1000053B1 (en) * 1997-07-25 2004-06-30 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Macrocyclic lactones, compositions, and methods of use
US7381744B1 (en) 1999-03-05 2008-06-03 The United States Of America As Represented By The Department Of Health And Human Services Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds
AU8083401A (en) * 2000-07-24 2002-02-05 Us Health Biologically active macrolides, compositions, and uses thereof

Also Published As

Publication number Publication date
CA2415611A1 (en) 2002-01-31
JP2004504399A (ja) 2004-02-12
WO2002008231A3 (en) 2002-06-27
US9820965B2 (en) 2017-11-21
US7144918B2 (en) 2006-12-05
US8741947B2 (en) 2014-06-03
ATE504589T1 (de) 2011-04-15
US9139595B2 (en) 2015-09-22
DE60144376D1 (de) 2011-05-19
US20150374661A1 (en) 2015-12-31
CA2415611C (en) 2011-03-15
US20060205707A1 (en) 2006-09-14
US20100298248A1 (en) 2010-11-25
US20140243284A1 (en) 2014-08-28
EP1303522A2 (en) 2003-04-23
EP1303522B1 (en) 2011-04-06
US20040087566A1 (en) 2004-05-06
WO2002008231A2 (en) 2002-01-31
JP4980542B2 (ja) 2012-07-18
AU2001280834B2 (en) 2006-08-10
US7790764B2 (en) 2010-09-07

Similar Documents

Publication Publication Date Title
IL117875A0 (en) Pharmaceutical compositions for inhibiting th growth of cancers
GEP19981299B (en) Method of Preparing Taxane Derivatives
IL107553A0 (en) Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
IN2001CH01053A (en) Methods for treating ovarian cancer, poly(phosphoester) compositions, and biodegradable articles for same
NL350075I2 (enExample)
BG104998A (en) Isothiazole derivatives useful as anticancer agents
WO1999029687A8 (en) (benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
AP2001002302A0 (en) 13-Methyl erythromycin derivatives.
NZ314003A (en) Medicaments for treating osteoporosis containing thiazolidine compounds
WO2001012169A3 (en) Method of cancer treatment
IL136359A0 (en) Dihydrobenzofuran derivatives and pharmaceutical compositions containing the same
EP1277744A4 (en) OXADIAZONE DERIVATIVES WITH ANTIBODY EFFECT
PL341050A1 (en) Heterocyclic cytoxic agents
MXPA03000547A (es) Uso de derivados de amidas de acido valproico y de acido 2-valproenico, para el tratamiento de manias en trastornos bipolares.
AP9801377A0 (en) Tricyclic erythromycin derivatives.
MX9805023A (es) Derivados de 1-metilcarbapenem.
MX9709451A (es) Derivados de benzisoxazol e indazol como agentes antipsicoticos.
BR9907172A (pt) Derivados de azatriciclo[3.3.1.1] decano e composições farmacêuticas contendo-os
AU8083401A (en) Biologically active macrolides, compositions, and uses thereof
IL108836A (en) C9 taxane derivatives and pharmaceutical compositions containing them
CA2374902A1 (en) Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation
NZ515478A (en) Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.
IL110828A (en) 10-BICYCLOHETEROALKYL OR ALKENYL-7-OXOPYRIDO £1, 2, 3-d, e| £1, 3, 4| BENZOXADIAZINE- 6-CARBOXYLIC ACID AND DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM